Artificial neural network method for predicting HIV protease cleavage sites in protein

被引:21
作者
Cai, YD [1 ]
Yu, H
Chou, KC
机构
[1] Chinese Acad Sci, Shanghai Res Ctr Biotechnol, Shanghai 200233, Peoples R China
[2] European Mol Biol Lab, D-69012 Heidelberg, Germany
[3] Upjohn Co, Upjohn Labs, Comp Aided Drug Discovery, Kalamazoo, MI 49001 USA
来源
JOURNAL OF PROTEIN CHEMISTRY | 1998年 / 17卷 / 07期
关键词
HIV protease; artificial neural network; T. Kohonen's self-organization model; cleavage sites;
D O I
10.1007/BF02780962
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Knowledge of the polyprotein cleavage sites by HIV protease will refine our understanding of its specificity, and the information thus acquired will be useful for designing specific and efficient HIV protease inhibitors. The search for inhibitors of HIV protease will be greatly expedited if one can find an accurate, robust, and rapid method for predicting the cleavage sites in proteins by HIV protease. In this paper, Kohonen's self-organization model, which uses typical artificial neural networks, is applied to predict the cleavability of oligopeptides by proteases with multiple and extended specificity subsites. We selected HIV-1 protease as the subject of study. We chose 299 oligopeptides for the training set, and another 63 oligopeptides for the test set. Because of its high rate of correct prediction (58/63 = 92.06%) and stronger fault-tolerant ability, the neural network method should be a useful technique for finding effective inhibitors bf HIV protease, which is one of the targets in designing potential drugs against AIDS. The principle of the artificial neural network method can also be applied to analyzing the specificity of any multisubsite enzyme.
引用
收藏
页码:607 / 615
页数:9
相关论文
共 31 条
[21]   STRUCTURE OF COMPLEX OF SYNTHETIC HIV-1 PROTEASE WITH A SUBSTRATE-BASED INHIBITOR AT 2.3-A RESOLUTION [J].
MILLER, M ;
SCHNEIDER, J ;
SATHYANARAYANA, BK ;
TOTH, MV ;
MARSHALL, GR ;
CLAWSON, L ;
SELK, L ;
KENT, SBH ;
WLODAWER, A .
SCIENCE, 1989, 246 (4934) :1149-1152
[22]   MOLECULAR TARGETS FOR AIDS THERAPY [J].
MITSUYA, H ;
YARCHOAN, R ;
BRODER, S .
SCIENCE, 1990, 249 (4976) :1533-1544
[23]   A STRUCTURAL MODEL FOR THE RETROVIRAL PROTEASES [J].
PEARL, LH ;
TAYLOR, WR .
NATURE, 1987, 329 (6137) :351-354
[24]  
POORMAN RA, 1991, J BIOL CHEM, V266, P14554
[25]   HOW ANTIBODIES BLOCK HIV-INFECTION - PATHS TO AN AIDS VACCINE [J].
PUTNEY, S .
TRENDS IN BIOCHEMICAL SCIENCES, 1992, 17 (05) :191-196
[26]   RATIONAL DESIGN OF PEPTIDE-BASED HIV PROTEINASE-INHIBITORS [J].
ROBERTS, NA ;
MARTIN, JA ;
KINCHINGTON, D ;
BROADHURST, AV ;
CRAIG, JC ;
DUNCAN, IB ;
GALPIN, SA ;
HANDA, BK ;
KAY, J ;
KROHN, A ;
LAMBERT, RW ;
MERRETT, JH ;
MILLS, JS ;
PARKES, KEB ;
REDSHAW, S ;
RITCHIE, AJ ;
TAYLOR, DL ;
THOMAS, GJ ;
MACHIN, PJ .
SCIENCE, 1990, 248 (4953) :358-361
[27]   HUMAN IMMUNODEFICIENCY VIRUS HAS AN ASPARTIC-TYPE PROTEASE THAT CAN BE INHIBITED BY PEPSTATIN-A [J].
SEELMEIER, S ;
SCHMIDT, H ;
TURK, V ;
VONDERHELM, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (18) :6612-6616
[28]   RETROVIRAL PROTEASE-LIKE SEQUENCE IN THE YEAST TRANSPOSON TY1 [J].
TOH, H ;
ONO, M ;
SAIGO, K ;
MIYATA, T .
NATURE, 1985, 315 (6021) :691-691
[29]  
TOMASSELLI AG, 1991, ADV EXP MED BIOL, V306, P469
[30]   STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASE [J].
WLODAWER, A ;
ERICKSON, JW .
ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :543-585